Kestra Medical Technologies, Ltd. Common Stock KMTS Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$34.17M-57.0% | -$32.79M-59.0% | -$25.83M-27.1% | -$51.11M-117% | -$21.76M+7.5% | ||
| $1.98M+5.0% | $2.37M+27.0% | $2.03M-14.6% | $1.84M-36.5% | $1.89M-34.7% | ||
| $10.11M+2,102% | $8.65M+671% | $4.58M+1,115% | $22.31M+5,898% | $459K+23.4% | ||
| —— | —— | —— | $16K+433% | $16K+433% | ||
| $469K+176% | $468K-29.2% | $469K+135% | $369K+142% | $170K+11.5% | ||
| -$167K+44.7% | -$280K+13.8% | -$280K-9.8% | -$1.21M-353% | -$302K-12.9% | ||
| $2.66M-20.4% | $1.71M+7.9% | $1.78M-38.5% | $963K+54.2% | $3.34M+435% | ||
| —— | —— | -$2.9M-228% | —— | $4.01M+119% | ||
| $3.67M+289% | $1.38M-16.2% | -$860K-714% | $1.89M+1,935% | $944K+918% | ||
| -$10K0.0% | -$10K0.0% | -$10K0.0% | -$10K-500% | -$10K-500% | ||
| —— | —— | —— | —— | —— | ||
| -$228K-319% | -$175K-272% | -$138K-727% | $142K+221% | $104K+189% | ||
| -$18.37M-2.1% | -$18.34M-1.6% | -$26.27M-50.1% | -$24.06M-33.2% | -$18M+0.3% | ||
| $9.8M+141% | $7.27M+63.4% | $8.17M+16.0% | $7.39M+142% | $4.06M+32.9% | ||
| -$14.92M-235% | -$7.42M-67.9% | -$8.23M-17.0% | -$7.4M-142% | -$4.45M-45.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $53.95M— | $53.95M— | ||
| —— | —— | —— | —— | —— | ||
| $149.18M— | -$27K— | -$1.88M-102% | $214.7M+1,005% | —— | ||
| $115.9M— | -$25.79M— | -$36.38M-140% | $183.24M+10,977% | —— | ||
| —— | $1.42M+15.6% | $1.42M+16.6% | $1.22M+34.7% | $1.18M+29.8% | ||
| $25K-34.2% | —— | -$39K— | $2K+127% | $38K+607% | ||
| $469K+176% | $468K-29.2% | $469K+135% | $369K+142% | $170K+11.5% | ||
| $3.67M+289% | $1.38M-16.2% | -$860K-714% | $1.89M+1,935% | $944K+918% | ||
| —— | -$136K+73.7% | -$460K+23.2% | -$620K-111% | -$1.71M-480% | ||
| -$228K-319% | -$175K-272% | -$138K-727% | $142K+221% | $104K+189% | ||
| —— | -$813K— | -$140K-136% | $1.42M+1,817% | $378K+557% | ||
| $125K+42.0% | $87K-3.3% | $61K-59.9% | $86K-52.8% | $88K-51.7% | ||
| —— | —— | —— | $152K-44.6% | $236K-14.0% | ||
| $365K-54.9% | $537K+45.9% | $613K-13.2% | $811K+549% | $809K+547% | ||
| $699K+311% | —— | —— | —— | $170K— | ||
| $189K-56.0% | $235K+32.8% | $103K+415% | $28K-61.1% | $430K+497% | ||
| $67K+55.8% | $80K-60.8% | $37K+60.9% | $13K-81.8% | $43K-39.6% | ||
| —— | —— | —— | $6K-97.0% | $50K-75.0% | ||
| —— | —— | —— | $880.75K— | $880.75K— | ||
| —— | —— | —— | —— | —— | ||
| $84K+21.7% | —— | —— | —— | $69K— | ||
| —— | —— | —— | $593.5K— | $593.5K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $468.75K— | $468.75K— | ||
| —— | —— | —— | $70.13M— | $70.13M— | ||
| -$232K-135% | —— | -$2.91M-539% | $662K— | $662K— | ||
| -$228K-319% | -$175K-272% | -$138K-727% | $142K+221% | $104K+189% | ||
| —— | —— | —— | $1.36M— | $1.36M— | ||
| $959K+35.6% | $1.41M— | $6.9M-18.8% | —— | $707K-74.4% | ||
| $25K-34.2% | —— | -$39K— | $2K+127% | $38K+607% | ||
| -$28.16M-27.7% | -$25.61M-13.8% | -$34.44M-40.4% | -$31.45M-48.9% | -$22.06M-4.5% | ||
| -$28.16M-27.7% | -$25.61M-13.8% | -$34.44M-40.4% | -$31.45M-48.9% | -$22.06M-4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Kestra Medical Technologies, Ltd. Common Stock generate?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated -$87.0M in operating cash flow over the trailing twelve months.
- What is Kestra Medical Technologies, Ltd. Common Stock's free cash flow?
- After $32.6M of capital expenditures, Kestra Medical Technologies, Ltd. Common Stock's free cash flow was -$119.7M over the trailing twelve months, down 32.6% year over year.
- Where does Kestra Medical Technologies, Ltd. Common Stock's cash flow data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
